Abstract
摘要
相似文献
1
[Therapeutic diagrams].
Hopital. 1953 Mar;41(620):76-9.
2
Lysivane in the treatment of Parkinsonism.
Edinb Med J. 1953 Aug;60(8):365-70.
3
[Pharmacokinetics in parkinsonism].
Geneeskd Gids. 1955 Aug 18;33(17):339-48.
4
Recurrent thioperazine-induced extrapyramidal reaction following placebo substitution for maintenance antiparkinson drug.
Am J Psychiatry. 1961 Oct;118:351-2. doi: 10.1176/ajp.118.4.351.
5
Parsidol in the treatment of Parkinson's syndrome.
Bull Los Angel Neuro Soc. 1956 Jun;21(2):80-3.
6
[Agranulocytosis due to diparcol].
Ned Tijdschr Geneeskd. 1952 Dec 6;96(49):3079-80.
7
Parsidol in the treatment of parkinsonism.
Neurology. 1955 Mar;5(3):197-200. doi: 10.1212/wnl.5.3.197.
8
[Artane therapy of paralysis agitans].
Ugeskr Laeger. 1952 Nov 20;114(47):1695-7.
9
Clinical trials of transergan in the parkinsonian syndrome.
Acta Med Scand. 1956 Jun 9;154(5):375-9. doi: 10.1111/j.0954-6820.1956.tb14332.x.
10
Trihexyphenidyl (artane), stramonium, and nonchemotherapy of paralysis agitans.
AMA Arch Neurol Psychiatry. 1952 Apr;67(4):462-72. doi: 10.1001/archneurpsyc.1952.02320160046005.
Zotero 插件